TY - JOUR
T1 - Acquired hemophilia A associated with autoimmune pancreatitis with serum IgG4 elevation
AU - Narazaki, Taisuke
AU - Haji, Shojiro
AU - Nakashima, Yasuhiro
AU - Tsukamoto, Yasuhiro
AU - Tsuda, Mariko
AU - Takamatsu, Akiko
AU - Ohno, Hirofumi
AU - Matsushima, Takamitsu
AU - Matsumoto, Tomoko
AU - Nogami, Keiji
AU - Shima, Midori
AU - Shiratsuchi, Motoaki
AU - Ogawa, Yoshihiro
N1 - Publisher Copyright:
© 2018, The Japanese Society of Hematology.
Copyright:
Copyright 2018 Elsevier B.V., All rights reserved.
PY - 2018/9/1
Y1 - 2018/9/1
N2 - A case of acquired hemophilia A (AHA) that developed in a patient with autoimmune pancreatitis (AIP) is presented. A 64-year-old woman was diagnosed with AIP in 2007. The symptoms resolved with prednisolone (PSL). Although the dose of PSL was tapered to 7.5 mg/day for maintenance, serum IgG4 levels remained high. She suddenly presented with subcutaneous bleeding in 2015. Her activated partial thromboplastin time was prolonged (80.0 s). A mixing test showed an inhibitor pattern, factor VIII (FVIII) activity was less than 1%, and FVIII inhibitor was 290 BU/mL. She was diagnosed with AHA. Her serum IgG4 was elevated to 133 mg/dL. She was treated first with PSL alone, but she developed bladder tamponade. Cyclophosphamide and activated prothrombin complex concentrate were combined with PSL. She then achieved hemostasis, and FVIII inhibitor disappeared. FVIII inhibitor had been detected since PSL was tapered and AHA recurred two months later. An enzyme-linked immunosorbent assay showed that the inhibitor was mainly IgG4 and IgG1. This case suggests that elevation of IgG4 may be associated with the development of both AHA and AIP.
AB - A case of acquired hemophilia A (AHA) that developed in a patient with autoimmune pancreatitis (AIP) is presented. A 64-year-old woman was diagnosed with AIP in 2007. The symptoms resolved with prednisolone (PSL). Although the dose of PSL was tapered to 7.5 mg/day for maintenance, serum IgG4 levels remained high. She suddenly presented with subcutaneous bleeding in 2015. Her activated partial thromboplastin time was prolonged (80.0 s). A mixing test showed an inhibitor pattern, factor VIII (FVIII) activity was less than 1%, and FVIII inhibitor was 290 BU/mL. She was diagnosed with AHA. Her serum IgG4 was elevated to 133 mg/dL. She was treated first with PSL alone, but she developed bladder tamponade. Cyclophosphamide and activated prothrombin complex concentrate were combined with PSL. She then achieved hemostasis, and FVIII inhibitor disappeared. FVIII inhibitor had been detected since PSL was tapered and AHA recurred two months later. An enzyme-linked immunosorbent assay showed that the inhibitor was mainly IgG4 and IgG1. This case suggests that elevation of IgG4 may be associated with the development of both AHA and AIP.
UR - http://www.scopus.com/inward/record.url?scp=85044468602&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85044468602&partnerID=8YFLogxK
U2 - 10.1007/s12185-018-2441-3
DO - 10.1007/s12185-018-2441-3
M3 - Article
C2 - 29582334
AN - SCOPUS:85044468602
SN - 0925-5710
VL - 108
SP - 335
EP - 338
JO - International Journal of Hematology
JF - International Journal of Hematology
IS - 3
ER -